Skip to main content
. Author manuscript; available in PMC: 2025 Aug 22.
Published in final edited form as: Am J Prev Med. 2025 May 28;69(2):107736. doi: 10.1016/j.amepre.2025.107736

Figure 2.

Figure 2.

Time to benefit in years for lung cancer screening to prevent lung cancer death at an absolute risk reduction of 0.001. NLST results were derived using individual data from the original dataset. The upper limit of 95% CI does not exceed 12.0 years due to censoring at 12 years of follow-up.